Skip to main content
. 2023 Aug 29;15(17):4321. doi: 10.3390/cancers15174321

Table 1.

Characteristics of included studies, with summary statistics of reported hypothyroidism incidence displayed by subgroup.

Factor Count (%)
N = 111
Estimated Hypothyroidism Incidence (%), Reported as Median (IQR)
Publication Year
2000 and prior 19 (17) 34 (21–43)
2001–2005 8 (7) 44 (40–47)
2006–2010 15 (14) 31.6 (20.8–45.3)
2011–2015 22 (20) 33.3 (22.8–45)
2016–2020 32 (29) 42.3 (25–46.2)
2021–2022 15 (14) 42 (30.4–54.3)
Design
Prospective 31 (28) 37 (27.4–47)
Retrospective 80 (72) 36.1 (24–46)
Interventional
Yes 4 (4) -
No 97 (96) -
Mean/Median Follow Up (months)
Min 6 -
First Quartile 21 -
Median 32 -
Third Quartile 50.2 -
Max 120 -
Unspecified/NA 24 -
Sample size Median 102 (62–184.75) -
Participant Type
Patients 99 (98) -
Physicians 2 (2) -
Cancer Site
General Head and Neck 64 (58) 36.7 (26–44.7)
Nasopharynx 28 (25) 35 (23–46.2)
Oropharynx 6 (5) 57.5 (35.3–62.5)
Larynx/Hypopharynx 10 (9) 39.5 (28.7–48.7)
Oral Cavity 3 (3) 17.9 (16.1–19.7)
Radiation Therapy Modality
Photons 87 (78) -
Photons/Electrons 2 (2) -
Particle Therapy 0 -
Unspecified 22 (20) -
Radiation Therapy Technique
IMRT 36 (32) 42 (27.4–49.1)
Non-IMRT (2D or 3DCRT) 38 (34) 35 (21.8–41.6)
IMRT and 3DCRT 10 (9) 46.5 (27.5–50.8)
MRI-guided radiotherapy 0 -
Unspecified/NA 27 (24) 35 (23.9–48.2)
Multimodality Therapy
All therapies allowed 89 (80) 36.4 (24.8–45.7)
Surgery excluded 13 (12) 38.8 (30–47)
Surgery required 4 (4) 38.6 (26.2–50.5)
Unspecified/NA 5 (5) 36.4 (25.4–48.2)
Thyroid Evaluation
Biochemical 73 (66) 38.8 (26.7–46.2)
Clinical 2 (2) 4.9
Biochemical and Clinical 32 (29) 31.1 (23.9–49.5)
Biochemical and Radiographic 2 (2) 42
Unspecified/NA * 2 (2) -

Abbreviations: 2D and 3DCRT; two-dimensional and three-dimensional conformal radiation therapy, IMRT; intensity-modulated radiation therapy * Refers to studies investigating physician practices regarding screening for hypothyroidism and thus were considered Unspecified/NA.